Literature DB >> 27821195

Characterizing the risk of respiratory syncytial virus in infants with older siblings: a population-based birth cohort study.

P Jacoby1, K Glass2, H C Moore1.   

Abstract

From a population-based birth cohort of 245 249 children born in Western Australia during 1996-2005, we used linkage of laboratory and birth record datasets to obtain data including all respiratory syncytial virus (RSV) detections during infancy from a subcohort of 87 981 singleton children born in the Perth metropolitan area from 2000 to 2004. Using log binomial regression, we found that the risk of infant RSV detection increases with the number of older siblings, with those having ⩾3 older siblings experiencing almost three times the risk (relative risk 2·83, 95% confidence interval 2·46-3·26) of firstborn children. We estimate that 45% of the RSV detections in our subcohort were attributable to infection from an older sibling. The sibling effect was significantly higher for those infants who were younger during the season of peak risk (winter) than those who were older. Although older siblings were present in our cohort, they had very few RSV detections which could be temporally linked to an infant's infection. We conclude that RSV infection in older children leads to less severe symptoms but is nevertheless an important source of infant infection. Our results lend support to a vaccination strategy which includes family members in order to provide maximum protection for newborn babies.

Entities:  

Keywords:  Epidemiology; household; respiratory syncytial virus; vaccine policy development

Mesh:

Year:  2016        PMID: 27821195      PMCID: PMC9507629          DOI: 10.1017/S0950268816002545

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  26 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics.

Authors:  Barney S Graham
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

4.  Association of rhinovirus infection with increased disease severity in acute bronchiolitis.

Authors:  Nikolaos G Papadopoulos; Maria Moustaki; Mariza Tsolia; Apostolos Bossios; Eleni Astra; Anargiroula Prezerakou; Dimitrios Gourgiotis; Dimitrios Kafetzis
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

Review 5.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; D James Nokes; Bradford D Gessner; Mukesh Dherani; Shabir A Madhi; Rosalyn J Singleton; Katherine L O'Brien; Anna Roca; Peter F Wright; Nigel Bruce; Aruna Chandran; Evropi Theodoratou; Agustinus Sutanto; Endang R Sedyaningsih; Mwanajuma Ngama; Patrick K Munywoki; Cissy Kartasasmita; Eric A F Simões; Igor Rudan; Martin W Weber; Harry Campbell
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

Review 6.  RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes.

Authors:  Eric A F Simões
Journal:  Manag Care       Date:  2008-11

7.  Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

Authors:  Caroline Breese Hall; Geoffrey A Weinberg; Aaron K Blumkin; Kathryn M Edwards; Mary A Staat; Andrew F Schultz; Katherine A Poehling; Peter G Szilagyi; Marie R Griffin; John V Williams; Yuwei Zhu; Carlos G Grijalva; Mila M Prill; Marika K Iwane
Journal:  Pediatrics       Date:  2013-07-22       Impact factor: 7.124

8.  Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness.

Authors:  Ann R Falsey; Janet E McElhaney; Jiri Beran; Gerrit A van Essen; Xavier Duval; Meral Esen; Florence Galtier; Pierre Gervais; Shinn-Jang Hwang; Peter Kremsner; Odile Launay; Geert Leroux-Roels; Shelly A McNeil; Andrzej Nowakowski; Jan Hendrik Richardus; Guillermo Ruiz-Palacios; Suzanne St Rose; Jeanne-Marie Devaster; Lidia Oostvogels; Serge Durviaux; Sylvia Taylor
Journal:  J Infect Dis       Date:  2014-01-29       Impact factor: 5.226

9.  Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children.

Authors:  Hannah C Moore; Nicholas de Klerk; Anthony D Keil; David W Smith; Christopher C Blyth; Peter Richmond; Deborah Lehmann
Journal:  J Paediatr Child Health       Date:  2011-11-14       Impact factor: 1.954

10.  Modelling the seasonal epidemics of respiratory syncytial virus in young children.

Authors:  Hannah C Moore; Peter Jacoby; Alexandra B Hogan; Christopher C Blyth; Geoffry N Mercer
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  7 in total

1.  Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia.

Authors:  C Morley; K Grimwood; S Maloney; R S Ware
Journal:  Epidemiol Infect       Date:  2018-03-21       Impact factor: 4.434

2.  The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.

Authors:  Pia Hardelid; Maximiliane Verfuerden; Jim McMenamin; Rosalind L Smyth; Ruth Gilbert
Journal:  Euro Surveill       Date:  2019-01

3.  Effect of delayed palivizumab administration on respiratory syncytial virus infection-related hospitalisation: A retrospective, observational study.

Authors:  Akiko Kamori; Yuya Morooka; Kenichiro Yamamura; Pin Fee Chong; Noriko Kuga; Yasushi Takahata; Koichi Sagawa; Kenji Furuno
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

4.  Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm?

Authors:  Emma Binns; Marianne Koenraads; Lidia Hristeva; Alix Flamant; Sebastian Baier-Grabner; Mervin Loi; Johanna Lempainen; Elise Osterheld; Bazlin Ramly; Jessica Chakakala-Chaziya; Niveditha Enaganthi; Silvia Simó Nebot; Danilo Buonsenso
Journal:  Pediatr Pulmonol       Date:  2021-10-13

5.  Risk of Transmission and Viral Shedding From the Time of Infection for Respiratory Syncytial Virus in Households.

Authors:  Hirono Otomaru; Johanna Beulah T Sornillo; Taro Kamigaki; Samantha Louise P Bado; Michiko Okamoto; Mariko Saito-Obata; Marianette T Inobaya; Edelwisa Segubre-Mercado; Portia P Alday; Mayuko Saito; Veronica L Tallo; Beatriz P Quiambao; Hitoshi Oshitani; Alex R Cook
Journal:  Am J Epidemiol       Date:  2021-12-01       Impact factor: 4.897

6.  Model-based estimates of transmission of respiratory syncytial virus within households.

Authors:  Ivy K Kombe; Patrick K Munywoki; Marc Baguelin; D James Nokes; Graham F Medley
Journal:  Epidemics       Date:  2018-12-15       Impact factor: 4.396

7.  Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting.

Authors:  Patricia T Campbell; Nicholas Geard; Alexandra B Hogan
Journal:  BMC Med       Date:  2020-11-12       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.